Reader Question: Modifier JW Will Help Make Up for Discarded Drugs

Why This Topic Matters

Practices that administer drugs from single-use vials may need to update billing and recordkeeping workflows to align with Medicare’s standardized approach for reporting discarded amounts. Understanding the policy scope helps reduce confusion and supports more consistent claims handling.

Article Sections

1. Question

   The opening question describes concerns about discarded drugs in a pain management setting and asks whether unused portions can be reported for payment.

2. Answer

   This section summarizes a CMS policy update, identifies the broader Medicare reporting change, and notes the related documentation expectations in the medical record.

3. Benefit

   This section discusses the general payment impact of reporting discarded drug or biological amounts in certain situations.

4. Example

   This section presents a general billing example involving partial use of a single-use vial and reporting of the remaining amount.

5. Example

   This section gives another billing example involving a partial dose from a single-use vial and how the billed quantity relates to the discarded remainder.

6. Explanation

   This section explains why a separate discarded-amount line is not appropriate in a specific billing-unit scenario and describes the resulting processing concern.

7. Analysis

   This closing section offers a brief editorial take on the policy change and its expected effect on revenue and coding workflow.

8. Link

   This final section points readers to the CMS reference document for additional information.